Amicus Therapeutics Inc. buy StockNews.com
Start price
16.11.24
/
50%
€9.20
Target price
16.11.25
-
Performance (%)
-11.96%
End price
17.11.25
€8.10
Summary
This prediction ended on 17.11.25 with a price of €8.10. The price of Amicus Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.96%. StockNews_com has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 0.082% | 0.082% | 105.932% |
| iShares Core DAX® | 2,29 % | 9,96 % | 14,44 % |
| iShares Nasdaq 100 | 4,54 % | 8,79 % | 40,87 % |
| iShares Nikkei 225® | 2,81 % | 14,08 % | 47,19 % |
| iShares S&P 500 | 3,10 % | 6,85 % | 31,17 % |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.45
26.10.25
26.10.25
-
26.10.26
26.10.26
62.62%
21.04.26
21.04.26
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.70
11.03.23
11.03.23
-
11.03.24
11.03.24
2.80%
12.03.24
12.03.24